Patents Assigned to HYWE Pharmaceuticals, Inc.
  • Patent number: 8507562
    Abstract: The present invention provides convergent processes for preparing (?)-beta-elemene, (?)-beta-elemenal, (?)-beta-elemenol, and (?)-beta-elemene fluoride and analogues thereof. Also provided are intermediates useful for preparing (?)-beta-elemene. The present invention further provides novel compositions based on analogues of (?)-beta-elemene, (?)-beta-elemenal, (?)-beta-elemenol, (?)-beta-elemene fluoride and methods for the treatment of cancer, such as brain tumor, lung cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric intestional cancer, and stomach cancer.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: August 13, 2013
    Assignee: HYWE Pharmaceuticals, Inc.
    Inventor: Lan Huang